Our mission is to ensure the generation of accurate and precise findings.
Please enter subscribe form shortcode
Please enter instagram feed shortcode
Our R&D facility is in TICEL Biopark – Chennai, India, in a total built-up area of ~15000sft. The facility has +50 fume hoods, material generation labs, process safety, and analytical labs to offer discovery and development services. From our R&D facility, we can synthesize from a few milligrams to generate a few kilos of starting materials, intermediates, and Active Pharmaceutical Ingredients (APIs). Leveraging our expertise and innovative approach, we collaborate closely with our clients to design robust and scalable solutions that accelerate their product development timelines. Our R&D is housed with NMR, ICP MS, HPLCs, and GCs to name a few.
Our manufacturing facility is coming up in Naidupet, Andhra Pradesh, India, which is ~100km from Chennai International Airport, India. The facility will be a world-class manufacturing site to produce starting materials, intermediates, and Active Pharmaceutical Ingredients (APIs). Our manufacturing facility is expected to cater to our customer’s needs scaling from a few kilos to multi-ton requirements. We can provide small-quantity manufacturing from the preclinical and early clinical phase to all clinical stages till commercial manufacturing at a larger scale. The manufacturing facility will be accredited by global regulatory agencies.
3xper will be offering a robust and seamless technology transfer process from lab to manufacturing, backed by business processes, rigorous review, and governance to facilitate our customer molecule journey.
Laboratories in 100+ states
Laboratory specialists
Material collection points
Patients diagnosed in 2022
Nam eget dui vel quam sodales semper quis porttitor tortor.
Nam eget dui vel quam sodales semper quis porttitor tortor.
Nam eget dui vel quam sodales semper quis porttitor tortor.
Nam eget dui vel quam sodales semper quis porttitor tortor.
Testing Begins many varios
suffered alten in some
Testing Begins many varios
suffered alten in some
Testing Begins many varios
suffered alten in some
Exerci tation ullamcorper suscipit lobortis nisl aliquip ex ea commodo claritatem insitamconse quat.Exerci tation ullamcorper suscipit loborti excommodo habent claritatem insitamconse quat.Exerci tationlobortis nisl aliquip ex ea commodo habent claritatem insitamconse quat.
Exerci tation ullamcorper suscipit lobortis nisl aliquip ex ea commodo claritatem insitamconse quat.Exerci tation ullamcorper suscip
Exerci tation ullamcorper suscipit lobortis nisl aliquip ex ea commodo claritatem insitamconse quat.Exerci tation ullamcorper suscipit loborti excommodo habent claritatem insitamconse quat.Exerci tationlobortis nisl aliquip ex ea commodo habent claritatem insitamconse quat.
Exerci tation ullamcorper suscipit lobortis nisl aliquip ex ea commodo claritatem insitamconse quat.Exerci tation ullamcorper suscip
Providing insight-driven transformation to investment banks, wealth and asset mana, exchanges, Finance
Providing insight-driven transformation to investment banks, wealth and asset mana, exchanges, Finance
Providing insight-driven transformation to investment banks, wealth and asset mana, exchanges, Finance
Providing insight-driven transformation to investment banks, wealth and asset mana, exchanges, Finance